A randomized, double-blind, placebo-controlled phase II study of maintenance therapy with tasquinimod (TASQ) in patients (pts) with mCRPC responsive to or stabilized during first-line docetaxel chemotherapy

Karim Fizazi, Albertas Ulys, Lisa Sengeløv, Mette Moe Kempel, Sylvain Ladoire, Antoine Thiery-Vuillemin, Aude Flechon, Roberto Sabbatini, Joaquim Bellmunt, Miguel Angel Climent, Simon Chowdhury, Herlinde Dumez, Michaela Matouskova, Nicolas Penel, Sigita Liutkauskiene, Lech Stachurski, Cora N. Sternberg, Frederique Baton, Nathalie Germann, Gedske Daugaard

Publikation: Bidrag til tidsskriftKonferenceabstrakt i tidsskriftForskningpeer review

OriginalsprogEngelsk
Artikelnummer201
TidsskriftJournal of Clinical Oncology
Vol/bind34
Udgave nummer2 Suppl.
ISSN0732-183X
StatusUdgivet - 2016
BegivenhedGenitourinary Cancers Symposium - San Francisco, USA
Varighed: 7 jan. 20169 jan. 2016

Konference

KonferenceGenitourinary Cancers Symposium
Land/OmrådeUSA
BySan Francisco
Periode07/01/201609/01/2016

Citationsformater